Provided By GlobeNewswire
Last update: Apr 1, 2025
SCOTTSDALE, Ariz., April 01, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (NASDAQ: DERM) (“Journey Medical” or the “Company”), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (“FDA”) approved prescription pharmaceutical products for the treatment of dermatological conditions, is pleased to announce the promotion of Ramsey Alloush, currently General Counsel, to the position of Chief Operating Officer (“COO”). Mr. Alloush will continue to also serve as the Company’s General Counsel.
Read more at globenewswire.com6.78
-0.19 (-2.73%)
NASDAQ:FBIO (6/13/2025, 8:00:02 PM)
1.85
-0.11 (-5.61%)
Find more stocks in the Stock Screener